Kenji Sawa
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 11, 2026
Association between pleurodesis before immunotherapy and pneumonitis in non-small cell lung cancer.
Journal: Respiratory investigation
Published: April 04, 2025
Relationship Between T790M Allele Frequency and Therapeutic Effects Before and After EGFR-TKI Administration Using Droplet Digital PCR in Non-small-cell Lung Cancer With EGFR Mutation.
Journal: Cancer diagnosis & prognosis
Published: February 02, 2025
Efficacy of ramucirumab combined with erlotinib or osimertinib in untreated EGFR-mutated NSCLC patients with asymptomatic brain metastases: insights from molecular biomarkers in the RELAY-brain trial.
Journal: Investigational new drugs
Published: October 03, 2024
Immunotherapy and Overall Survival Among Patients With Advanced Non-Small Cell Lung Cancer and Obesity.
Journal: JAMA network open
Published: August 02, 2024
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer.
Journal: Scientific reports
Published: March 26, 2024
Combination of transbronchoscopic oxygen insufflation and a digital chest drainage system in endobronchial occlusion: a hybrid technique for localization of fistula in intractable pneumothorax.
Journal: BMC pulmonary medicine
Published: March 25, 2024
Immune Checkpoint Inhibitor Is Associated with Improved Survival in Advanced Non-small Cell Lung Cancer Occurring in Patients with Autoimmune Disease.
Journal: Biological & pharmaceutical bulletin
Published: February 21, 2024
Insulin-like growth factor 1 receptor expression correlates with programmed death ligand 1 expression and poor survival in non-small cell lung cancer.
Journal: PloS one
Published: January 04, 2024
Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer.
Journal: Cancer science
Published: October 03, 2023
Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study.
Journal: Clinical lung cancer
Published: October 01, 2023
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
Journal: British journal of cancer
Published: September 03, 2023
Last Updated: 09/26/2026